title: Inoculation of Staphylococcus xylosus in SJL/J mice to determine pathogenicity.
abstract: An experimental study was performed to investigate whether intradermal tail inoculations of Staphylococcus xylosus would result in pathologic lesions in the SJL/J strain of mice (Mus musculus). This organism historically has been classified as a nonpathogenic, commensal bacterium associated with skin and mucous membranes and rarely implicated in infections. In this study, SJL/J mice inoculated with S. xylosus developed cutaneous tail lesions post-inoculation, and the organism was recovered from those lesions. Inoculation was accomplished by surgically inserting silk suture impregnated with the concentrated suspension of bacteria. In addition, a superficial abrasion was created adjacent to the suture, and a bacterial suspension was applied. Approximately 80% of the mice in the inoculated groups developed dermatologic lesions, compared with 0% in the control group. Mice with lesions were treated with Sulfamethoxazole-Trimethoprim in the drinking water continuously for 28 days. For the mice assigned to the treatment group, this treatment resulted in resolution of the cutaneous tail lesions.
authors.affiliation: Uniformed Services University of the Health Sciences (USUHS), 4301 Jones Bridge Road, Bethesda, MD 20814, USA.
authors.forename: Venita B
authors.initials: VB
authors.lastname: Thornton
authors.forename: Judith A
authors.initials: JA
authors.lastname: Davis
authors.forename: Mark B
authors.initials: MB
authors.lastname: St  Clair
authors.forename: Marlene N
authors.initials: MN
authors.lastname: Cole
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D051379:Mice; D008815:Mice, Inbred Strains; D009894:Opportunistic Infections; D013047:Specific Pathogen-Free Organisms; D013207:Staphylococcal Skin Infections / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D013210:Staphylococcus / Q000145:classification / Q000472:pathogenicity*; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination